Search
forResearch 10 of 145
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →